active substance: glycine;
1 tablet contains 100 mg of 100% glycine; excipients: ammonium methacrylate copolymer dispersion, montan glycol wax, povidone, calcium stearate.
Medicinal form. Tablets.
The main physicochemical properties: tablets are almost white or white with a creamy shade of color, round in shape with a flat surface with a chamfer. The surface of the tablets may be marble.
Pharmacotherapeutic group. Means affecting the nervous system.
Indication.
Functional and organic diseases of the nervous system (neuroses, neurosis-like states, vegetative-vascular dystonias, consequences of neuroinfection, brain injury, perinatal and other forms of encephalopathy, including alcoholic genesis), which are accompanied by increased excitability, emotional instability, reduced mental capacity, sleep disturbance.
Ischemic stroke and impaired cerebral circulation.
As an aid in the treatment of alcoholism.
Contraindication.
Individual intolerance of the medicinal product and increased sensitivity to its individual components; arterial hypotension. Children’s age up to 3 years.
Method of application and dosage.
Glycysed® medicine is used in tablets or in the form of powder after crushing the tablet transbuccally (by placement behind the cheek or in the oral cavity) or sublingually (under the tongue). The tablet is kept in the oral cavity until it is completely dissolved.
Children over 3 years of age, adolescents, and adults with reduced mental capacity are prescribed Glicised® 1 tablet (100 mg) 2─3 times a day for 14─30 days. The maximum daily dose is 300 mg.
Children aged 3 years and older and adults with increased excitability, emotional lability are prescribed 1 tablet 2─3 times a day, the course of treatment─7─14 days. If necessary, the course of treatment is repeated.
For sleep disorders, 50─100 mg are prescribed 20 minutes before bedtime or immediately before bedtime.
In case of ischemic cerebral stroke and disorders of cerebral blood circulation, 1 g of the drug is prescribed transbuccally or sublingually (if necessary, the tablet should be crushed) during the first 3─6 hours after the development of the stroke, then─for 1─5 days at 1 g per day, then for 6─30 days ─ 1─2 tablets 3 times a day.
In the treatment of alcoholism, the drug is prescribed as an auxiliary agent, 1 tablet 2─3 times a day for 14─30 days. If necessary, the course of treatment is repeated 4─6 times a year.
Children.
The drug is used for children over 3 years of age.
Adverse reactions.
The drug is usually well tolerated. With individual hypersensitivity, the development of allergic reactions, as well as rash, itching, urticaria, rhinitis, sore throat, conjunctivitis, weakness is possible. From the side of the gastrointestinal tract, the development of dyspeptic phenomena is possible, including pain in the epigastrium, nausea. From the side of the nervous system, isolated cases of impaired concentration, headache, tension, irritability were observed.
Expiration date.
3 years. Do not use after the expiration date indicated on the package.
Storage conditions.
Store in the original packaging at a temperature not higher than 25 °C.
Keep out of the reach of children.
Packaging.
10 tablets in a blister. 5 blisters in a pack.
Leave category.
Without a prescription.
Producer.
PJSC “Kyivmedpreparat”.
.
